Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab182901-100μg
|
100μg |
10
|
$89.90
|
|
|
Ab182901-1mg
|
1mg |
4
|
$419.90
|
|
|
Ab182901-5mg
|
5mg |
1
|
$1,089.90
|
|
|
Ab182901-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,749.90
|
|
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Cilgavimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, Human IgG1 |
|---|---|
| Synonyms | Spike RBD antibody | Anti-Spike RBD antibody | Anti-Human Spike RBD Recombinant Antibody | Anti-Spike RBD Reference Antibody | SARS-CoV-2 antibody | Anti-SARS-CoV-2 antibody | AZD-1061 | COV2-2130 |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | Spike RBD |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Cilgavimab (anti-Spike RBD) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab. Cilgavimab (anti-Spike RBD) shows protective action on mouse models of SARS-CoV-2 infection. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 26.6 kDa (Light Chain) & 52.4 kDa (Heavy Chain), under reducing conditions; 194.1 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 2420563-99-9 |
Cilgavimab (anti-Spike RBD) (Ab182901) - ELISA
Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 1.0 μg/mL can bind Cilgavimab (anti-Spike RBD) (Ab182901) with the EC50 of 173.8 ng/mL.
Cilgavimab (anti-Spike RBD) (Ab182901) - SEC
The purity of Cilgavimab (anti-Spike RBD) (Ab182901) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 03, 2024 | Ab182901 | |
| Certificate of Analysis | Jun 03, 2024 | Ab182901 | |
| Certificate of Analysis | Jun 03, 2024 | Ab182901 |
Starting at $89.90
Starting at $49.90
Starting at $99.90
Starting at $19.90
Starting at $59.90
Starting at $19.90
Starting at $49.90
Starting at $59.90
Starting at $39.90
Starting at $19.90
Starting at $89.90
Starting at $89.90
Starting at $16.90
Starting at $99.90
Starting at $49.90
Starting at $59.90
Starting at $59.90
Starting at $109.90
Starting at $19.90
Starting at $19.90